HeartWare International, a provider of less invasive, miniaturised circulatory support medacal devices for advanced heart failure, has received US Food and Drug Administration (FDA) approval for an investigational device exemption (IDE) supplement to enroll a second allotment of 54 patients in its ‘Advance’ bridge-to-transplant clinical trial under a continued access protocol (CAP).

Read more from the original source:
FDA approves second patient allotment to HeartWare Advance clinical trial

Accentus Medical, a UK based supplier of advanced coatings and surface treatments to the medical device industry, has signed a licence and services agreement with Zimmer, enabling Accentus’ Agluna anti-infective technology use on a broad range of Zimmer products.

Continue reading here:
Accentus, Zimmer sign licence agreement for Agluna anti-infective technology

Miraculins, a medical diagnostic company developing and commercialising diagnostic tests, has completed the acquisition from PreMD of all assets relating to the Prevu skin cholesterol test.

Read the original:
Miraculins acquires Prevu skin cholesterol test

Stentys, a developer of stents for the treatment of Acute Myocardial Infarction (AMI), has appointed Stanislas Piot as chief financial officer, effective immediately.

Read this article:
Stentys appoints new chief financial officer

Derma Sciences, a medical device company focused on advanced wound care, has received Healthcare Common Procedural Coding System (HCPCS) codes for all five products in its line of Xtrasorb HCS dressings.

See the original post here:
Derma Sciences Xtrasorb HCS dressings receive federal reimbursement codes